Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People
NCT06083766 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2025-11-10
Summary
The primary purpose of this research is to determine how gender affirming hormone therapy affects muscle physiology.
Conditions
- Effects of GAHT, on Skeletal Muscle in TGD
Interventions
- BEHAVIORAL
-
hormone therapy
Determine how gender affirming hormone therapy affects muscle physiology
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-04
- Primary Completion
- 2026-04-30
- Completion
- 2026-07-31
Countries
- United States
Study Locations
More Related Trials
-
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
NCT06939257 ·Status: RECRUITING
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
NCT04596592 ·Status: RECRUITING
-
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
NCT06116201 ·Status: COMPLETED ·Phase: NA
-
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
NCT04066283 ·Status: COMPLETED
-
Metabolic Consequences of Cross-sex Hormonal Treatment
NCT04508231 ·Status: UNKNOWN
-
The Anabolic Effects of Estrogen on Skeletal Muscles
NCT03020953 ·Status: COMPLETED ·Phase: NA
-
Estradiol-Receptor Blockade in Older Men and Women
NCT02271282 ·Status: COMPLETED ·Phase: PHASE1
-
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
NCT06291675 ·Status: RECRUITING
-
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
NCT06245681 ·Status: RECRUITING
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
NCT06969326 ·Status: RECRUITING ·Phase: PHASE3
-
Prevention of Obesity in Women Via Estradiol Regulation
NCT00687739 ·Status: COMPLETED ·Phase: PHASE3
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Coagulation and Fibrinolysis of Estradiol in Transwomen
NCT05387577 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A New Hormone Replacement Paradigm: Physiologic Restoration Study
NCT04190927 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
NCT07187947 ·Status: RECRUITING
-
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT05469204 ·Status: COMPLETED ·Phase: PHASE4
-
Transgender Estradiol Affirming Therapy
NCT05010707 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria
NCT06351501 ·Status: RECRUITING ·Phase: PHASE3
-
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
NCT02272647 ·Status: COMPLETED ·Phase: PHASE1
-
Extracellular Vesicles and Endothelial Function in Transgender Subjects
NCT04971447 ·Status: UNKNOWN ·Phase: NA
-
Transdermal Estrogen in Women With Anorexia Nervosa
NCT03875378 ·Status: RECRUITING ·Phase: PHASE2
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men
NCT00740194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Sexual Effects of Transdermal or Vaginal Testosterone
NCT06794346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2